These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4977745)

  • 1. Experimental observations on the antimycobacterial activity of rifampin.
    Hobby GL LENERT TF; Maier-Engallena J
    Proc Soc Exp Biol Med; 1969 Jun; 131(2):323-6. PubMed ID: 4977745
    [No Abstract]   [Full Text] [Related]  

  • 2. Ambroxol Induces Autophagy and Potentiates Rifampin Antimycobacterial Activity.
    Choi SW; Gu Y; Peters RS; Salgame P; Ellner JJ; Timmins GS; Deretic V
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 30012752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction aspects of antimycobacterial drugs in the chemotherapy of tuberculosis. II. The role of rifampicin and other drugs in the dependent or independent action of drug associations in vitro.
    Trnka L; Mison P; Staflova S
    Chemotherapy; 1974; 20(2):82-91. PubMed ID: 4210894
    [No Abstract]   [Full Text] [Related]  

  • 4. The antimycobacterial activity of rifampin.
    Hobby GL; Lenert TF
    Am Rev Respir Dis; 1968 Apr; 97(4):713-4. PubMed ID: 4966953
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experimental evaluation of the antimycobacterial activity of rifampicin].
    Ninni A; Scoles E; Iodice F; Razza I
    Arch Tisiol Mal Appar Respir; 1968 Apr; 23(4):315-28. PubMed ID: 4981410
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro activity of isoimperatorin, alone and in combination, against Mycobacterium tuberculosis.
    Guo N; Wu J; Fan J; Yuan P; Shi Q; Jin K; Cheng W; Zhao X; Zhang Y; Li W; Tang X; Yu L
    Lett Appl Microbiol; 2014 Apr; 58(4):344-9. PubMed ID: 24330002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic activities of clarithromycin and pyrazinamide against Mycobacterium tuberculosis in human macrophages.
    Mor N; Esfandiari A
    Antimicrob Agents Chemother; 1997 Sep; 41(9):2035-6. PubMed ID: 9303411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutting costs on mono-resistant tuberculosis diagnosis could eventually end up being more expensive.
    Rouzaud F; Robledo J
    Indian J Med Microbiol; 2010; 28(4):412-3. PubMed ID: 20966587
    [No Abstract]   [Full Text] [Related]  

  • 9. The "in vitro" activity of rifampicin compared with ethambutol, capreomycin and isoniazid.
    Steinbrück PW
    Acta Tuberc Pneumol Belg; 1969; 60(3):413-6. PubMed ID: 4984421
    [No Abstract]   [Full Text] [Related]  

  • 10. [An investigation on multiple drug resistance of the rifampin resistant strains of Mycobacterium tuberculosis].
    Kuang T; Jin G; Song P; Li W; Wang Z
    Wei Sheng Wu Xue Bao; 1998 Apr; 38(2):152-4. PubMed ID: 12549378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug resistance in tuberculosis.
    Ebrahim GJ
    J Trop Pediatr; 2007 Jun; 53(3):147-9. PubMed ID: 17526511
    [No Abstract]   [Full Text] [Related]  

  • 12. [Resistance to antitubercular drugs in Chile].
    Valenzuela MT; Scheel G; Ponce J; Lepe R; Velasco M; Valenzuela P
    Rev Med Chil; 1984 Jan; 112(1):76-80. PubMed ID: 6429808
    [No Abstract]   [Full Text] [Related]  

  • 13. [Molecular medicine and treatment of tuberculosis].
    Perel'man MI; Khomiakov IuN; Kiselev VI; Severin ES; Pal'tsev MA
    Probl Tuberk; 2001; (5):5-7. PubMed ID: 11588966
    [No Abstract]   [Full Text] [Related]  

  • 14. [Newest tuberculostatics; importance and feasibility of evaluation in a test tube].
    Trnka L; Havel A; Urbancik R
    Chemotherapy; 1966; 11(2):121-34. PubMed ID: 4959376
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro synergistic interactions of oleanolic acid in combination with isoniazid, rifampicin or ethambutol against Mycobacterium tuberculosis.
    Ge F; Zeng F; Liu S; Guo N; Ye H; Song Y; Fan J; Wu X; Wang X; Deng X; Jin Q; Yu L
    J Med Microbiol; 2010 May; 59(Pt 5):567-572. PubMed ID: 20075118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulfamethoxazole enhances the antimycobacterial activity of rifampicin.
    Macingwana L; Baker B; Ngwane AH; Harper C; Cotton MF; Hesseling A; Diacon AH; van Helden P; Wiid I
    J Antimicrob Chemother; 2012 Dec; 67(12):2908-11. PubMed ID: 22875849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic potential of peptide deformylase inhibitors against experimental tuberculosis.
    Sharma A; Khuller GK; Kanwar AJ; Sharma S
    J Infect; 2010 Jun; 60(6):498-501. PubMed ID: 20346970
    [No Abstract]   [Full Text] [Related]  

  • 18. [Testing Mycobacterium tuberculosis for drug sensitivity using different methods].
    Skriagina EM; Zalutskaia OM; Roth A; Mauch H; Nikolenko EN
    Probl Tuberk; 2001; (5):43-5. PubMed ID: 11588962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of mycobacteria growth indicator tubes for susceptibility testing of Mycobacterium tuberculosis to isoniazid and rifampin.
    Reisner BS; Gatson AM; Woods GL
    Diagn Microbiol Infect Dis; 1995 Aug; 22(4):325-9. PubMed ID: 8582137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies on the assay method of microbiologically active concentrations in the sensitivity test media for antituberculous agents. 2].
    Kanazawa Y; Kuramata T
    Kekkaku; 1970 Dec; 45(12):423-8. PubMed ID: 4992793
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.